Avoid common mistakes on your manuscript.
Dear Editors,
Since the world was hit by the pandemic of coronavirus disease 2019 (COVID-19), it has spread rapidly worldwide. The clinical impact of the SARS-CoV-2 infection in children is limited compared with adults. Therefore, clinical data on COVID-19 in children during the management of nephrotic syndrome (NS) is also lacking. To date, only one case who developed COVID-19 with simultaneous onset of NS has been reported [1]. A report from Spain described 16 patients with chronic kidney diseases presenting mild respiratory symptoms and a few radiological manifestations. Of these, two patients with steroid-dependent nephrotic syndrome had relapsed, but the prednisone treatment response was good in both cases [2]. Here we encountered a pediatric patient with the recurrence of NS triggered by SARS-CoV-2 infection.
The patient was a 3-year-old Japanese boy diagnosed with NS, for which he received induction therapy with prednisolone (2 mg/kg/day) and achieved complete remission. During the process of prednisolone tapering, the patient was tested using the polymerase chain reaction test for SARS-CoV-2 because he had been in close contact with the infection and subsequently tested positive. He was transferred and admitted to our hospital for the concurrent management of COVID-19 and NS. On admission, no abnormalities were observed following a general physical examination except for a high fever and eyelid edema. Additionally, a urinary qualitative analysis revealed that the urinary protein level was positive. Urinary protein level was 6.3 g/gCr. Hematologic examination revealed white blood cells 10,700/μL (neutrophils 90.0%, lymphocytes 7.1%), hemoglobin 13.4 g/dL, and platelets 252,000/μL. Serum creatinine (0.18 mg/dL) and blood urea nitrogen (4.0 mg/dL) were normal. C-reactive protein was slightly elevated at 0.37 mg/dL. Serum total protein and albumin were slightly decreased, 6.3 mg/dL and 3.5 mg/dL, respectively. The lactate dehydrogenase level was slightly elevated, 348 U/dL. Chest computed tomography imaging showed no consolidations and ground glass opacity. His fever lowered for only 1 day without treatment for COVID-19. Since the urinary protein level increased, we treated him with prednisolone dosed up to 2 mg/kg/day regarded as recurrence. Urinary findings gradually improved, with remission occurring a week after treatment was initiated.
To our knowledge, this is the first reported case with the recurrence of NS triggered by the SARS-CoV-2 infection in Asia. No treatment for SARS-CoV-2 infection has been established yet. A few reports, including our case, support that daily administration of maintenance doses of prednisolone may be effective for managing the relapse of NS associated with SARS-CoV-2 infection.
References
Alvarado A, Franceschi G, Resplandor E, Sumba J, Orta N (2020) COVID-19 associated with onset nephrotic syndrome in a pediatric patient: coincidence or related conditions? Pediatr Nephrol. https://doi.org/10.1007/s00467-020-04724-y
Melgosa M, Madrid A, Alvárez O, Lumbreras J, Nieto F, Parada E, Perez-Beltrán V, Spanish Pediatric Nephrology Association (2020) SARS-CoV-2 infection in Spanish children with chronic kidney pathologies. Pediatr Nephrol 35:1521–1524. https://doi.org/10.1007/s00467-020-04597-1
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Enya, T., Sugimoto, K. SARS-CoV-2 infection associated with the recurrence of nephrotic syndrome in a Japanese boy. Pediatr Nephrol 36, 209 (2021). https://doi.org/10.1007/s00467-020-04782-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00467-020-04782-2